Citations (237)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Per Even Storli, Rachel Genne Dille-Amdam, Gaute Havik Skjærseth, Mads Vikhammer Gran, Tor Åge Myklebust, Jon Erik Grønbech & Erling A. Bringeland. (2023) Cumulative incidence of first recurrence after curative treatment of stage I–III colorectal cancer. Competing risk analyses of temporal and anatomic patterns. Acta Oncologica 62:12, pages 1822-1830.
Read now
Read now
Song Van Nguyen, Levar Shamoun, Kalle Landerholm, Dick Wågsäter & Jan Dimberg. (2023) Clinicopathological and prognostic value of CD44 gene polymorphism (rs187115) in Swedish patients with colorectal cancer. Nucleosides, Nucleotides & Nucleic Acids 42:10, pages 807-817.
Read now
Read now
Liyun Ji, Zeyuan Wang, Yin Ji, Huiyu Wang, Miao Guo, Lu Zhang, Peng Wang & Hua Xiao. (2022) Proteomics and phosphoproteomics analysis of tissues for the reoccurrence prediction of colorectal cancer. Expert Review of Proteomics 19:4-6, pages 263-277.
Read now
Read now
E. Osterman, J. Ekström, T. Sjöblom, H. Kørner, T. Å. Myklebust, M. G. Guren & B. Glimelius. (2021) Accurate population-based model for individual prediction of colon cancer recurrence. Acta Oncologica 60:10, pages 1241-1249.
Read now
Read now
Erik Osterman, Klara Hammarström, Israa Imam, Emerik Osterlund, Tobias Sjöblom & Bengt Glimelius. (2021) Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer. Acta Oncologica 60:7, pages 842-849.
Read now
Read now
Mingli Li, Yuanyuan Jin & Yuanzhi Li. (2019) LncRNA TP73-AS1 Activates TGF-β1 to Promote the Migration and Invasion of Colorectal Cancer Cell. Cancer Management and Research 11, pages 10523-10529.
Read now
Read now
Bengt Glimelius & Peter Nygren. (2019) Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer. Acta Oncologica 58:4, pages 395-397.
Read now
Read now
Bengt Glimelius. (2018) Forty-five years in oncology, 25 years with Acta Oncologica. Acta Oncologica 57:12, pages 1593-1598.
Read now
Read now
Eetu Heervä, Anu Carpelan, Samu Kurki, Jari Sundström, Heikki Huhtinen, Arto Rantala, Annika Ålgars, Raija Ristamäki, Olli Carpén & Heikki Minn. (2018) Trends in presentation, treatment and survival of 1777 patients with colorectal cancer over a decade: a Biobank study. Acta Oncologica 57:6, pages 735-742.
Read now
Read now
Torben Frøstrup Hansen, Sanne Kjær-Frifeldt, Jan Lindebjerg, Søren Rafael Rafaelsen, Lars Henrik Jensen, Anders Jakobsen & Flemming Brandt Sørensen. (2018) Tumor–stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy. Acta Oncologica 57:4, pages 528-533.
Read now
Read now
Bengt Glimelius. (2018) More than 1000 new manuscripts in 2017. Acta Oncologica 57:2, pages 174-175.
Read now
Read now
Ashley C. Holmes, Anders H. Riis, Rune Erichsen, Veronika Fedirko, Eva Bjerre Ostenfeld, Mogens Vyberg, Ole Thorlacius-Ussing & Timothy L. Lash. (2017) Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study. Acta Oncologica 56:8, pages 1111-1119.
Read now
Read now
Camilla Böckelman & Bengt Glimelius. (2017) Need for adjuvant chemotherapy after colon cancer surgery – has it decreased?. Acta Oncologica 56:5, pages 629-633.
Read now
Read now
Hiroaki Nozawa, Soichiro Ishihara, Kazushige Kawai, Keisuke Hata, Tomomichi Kiyomatsu, Toshiaki Tanaka, Takeshi Nishikawa, Kensuke Otani, Koji Yasuda, Kazuhito Sasaki, Koji Murono & Toshiaki Watanabe. (2017) A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer. Acta Oncologica 56:5, pages 634-638.
Read now
Read now
Bengt Glimelius. (2016) What is most relevant in preoperative rectal cancer chemoradiotherapy – the chemotherapy, the radiation dose or the timing to surgery?. Acta Oncologica 55:12, pages 1381-1385.
Read now
Read now
Maziar Nikberg, Abbas Chabok, Henry Letocha, Csaba Kindler, Bengt Glimelius & Kenneth Smedh. (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncologica 55:12, pages 1418-1424.
Read now
Read now
Nobuaki Hoshino, Suguru Hasegawa, Koya Hida, Kenji Kawada, Riki Ganeko, Kenichi Sugihara & Yoshiharu Sakai. (2016) Nomogram for predicting recurrence in stage II colorectal cancer. Acta Oncologica 55:12, pages 1414-1417.
Read now
Read now
Luka Stanisavljević, Mette P. Myklebust, Sabine Leh & Olav Dahl. (2016) LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Acta Oncologica 55:12, pages 1425-1433.
Read now
Read now
Lubna Mehdawi, Janina Osman, Geriolda Topi & Anita Sjölander. (2016) High tumor mast cell density is associated with longer survival of colon cancer patients. Acta Oncologica 55:12, pages 1434-1442.
Read now
Read now
Måns Stefansson & Peter Nygren. (2016) Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life. Acta Oncologica 55:9-10, pages 1227-1235.
Read now
Read now
Renate S. Olsen, Roland E. Andersson, Niklas Zar, Sture Löfgren, Dick Wågsäter, Andreas Matussek & Jan Dimberg. (2016) Prognostic significance of PLA2G4C gene polymorphism in patients with stage II colorectal cancer. Acta Oncologica 55:4, pages 474-479.
Read now
Read now
Bengt Glimelius & Nina Cavalli-Björkman. (2016) Does shared decision making exist in oncologic practice?. Acta Oncologica 55:2, pages 125-128.
Read now
Read now
Kaisa Ahopelto, Camilla Böckelman, Jaana Hagström, Selja Koskensalo & Caj Haglund. (2016) Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer. Cancer Biology & Therapy 17:2, pages 163-168.
Read now
Read now
Bengt Glimelius. (2015) What’s new about Acta Oncologica for 2016?. Acta Oncologica 54:10, pages 1703-1705.
Read now
Read now
Rebecca Y Tay, Rachel Wong & Eliza A Hawkes. (2015) Treatment of metastatic colorectal cancer: focus on panitumumab. Cancer Management and Research 7, pages 189-198.
Read now
Read now
Bengt Glimelius. (2015) Adjuvant chemotherapy for patients with rectal cancer – will the controversy be resolved?. Acta Oncologica 54:4, pages 433-436.
Read now
Read now
Olav Dahl & Frank Pfeffer. (2015) Twenty-five years with adjuvant chemotherapy for colon cancer – a continuous evolving concept. Acta Oncologica 54:1, pages 1-4.
Read now
Read now
Articles from other publishers (210)
Junhui Yu, Yanyan Bai, Lan Jin, Zhongtao Zhang & Yingchi Yang. (2023) A Prospective Long-Term Follow-Up Study: The Application of Circulating Tumor Cells Analysis to Guide Adjuvant Therapy in Stage II Colorectal Cancer. Annals of Surgical Oncology 30:13, pages 8495-8500.
Crossref
Crossref
Kelsey McHugh & Rish K. Pai. (2023) Deep Learning and Colon Cancer Interpretation. Surgical Pathology Clinics 16:4, pages 651-658.
Crossref
Crossref
Li Yang, Jinlin Yang, Andreas Kleppe, Håvard E. Danielsen & David J. Kerr. (2023) Personalizing adjuvant therapy for patients with colorectal cancer. Nature Reviews Clinical Oncology.
Crossref
Crossref
Mesnad S. Alyabsi, Anwar H. Alqarni, Adel F. Almutairi, Nahar A. Alselaim, Mohammed A. Algarni & Kanan M. Alshammari. (2023) Real-life experiences and barriers to adjuvant chemotherapy in Saudi patients with advanced stage II and stage III colon cancer. Saudi Journal of Gastroenterology.
Crossref
Crossref
Allan M. Golder, Owen Conlan, Donald C. McMillan, David Mansouri, Paul G. Horgan & Campbell S. Roxburgh. (2023) Adverse Tumour and Host Biology May Explain the Poorer Outcomes Seen in Emergency Presentations of Colon Cancer. Annals of Surgery 278:5, pages e1018-e1025.
Crossref
Crossref
Kelly M. Mahuron & Yuman Fong. (2023) Applications of Liquid Biopsy for Surgical Patients With Cancer. JAMA Surgery.
Crossref
Crossref
Feng Pi, Gang Tang, Chaozheng Xie, Yukun Cao, Shilai Yang & Zhengqiang Wei. (2023) A retrospective study analyzing if lymph node ratio carbon nanoparticles predict stage III rectal cancer recurrence. Frontiers in Oncology 13.
Crossref
Crossref
Iin Narwanti, Zih-Yao Yu, Bidyadhar Sethy, Mei-Jung Lai, Hsueh-Yun Lee, Popazova Olena, Sung-Bau Lee & Jing-Ping Liou. (2023) 6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancers. European Journal of Medicinal Chemistry 258, pages 115505.
Crossref
Crossref
Gudrun Lindmark, Lina Olsson, Basel Sitohy, Anne Israelsson, Joel Blomqvist, Sara Kero, Tamer Roshdy, Mattias Söderholm, Annamaria Turi, Jessica Isaksson, Thorbjörn Sakari, Michiel Dooper, George Dafnis, Pehr Forsberg, Susanne Skovsted, Maria Walldén, Chih‐Han Kung, Martin Rutegård, Johanna Nordmyr, Måns Muhrbeck, Sten Hammarström & Marie‐Louise Hammarström. (2023)
qRT‐PCR
analysis of
CEACAM5
,
KLK6
,
SLC35D3
,
MUC2
and
POSTN
in colon cancer lymph nodes—An improved method for assessment of tumor stage and prognosis
. International Journal of Cancer.
Crossref
Crossref
Meridith C. Ginesi, Jonathan T. Bliggenstorfer, Daphine M. Kwesiga, Samantha H. Xu, Diana Jodeh, J. Eva Selfridge, Sharon L. Stein & Emily F. Steinhagen. (2023) Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer. Annals of Surgical Oncology 30:9, pages 5511-5518.
Crossref
Crossref
Jeongseok Jeon, Da Bin Lee, Sang Joon Shin, Dai Hoon Han, Jee Suk Chang, Yoon Dae Han, Hyunwook Kim, Joon Seok Lim, Han Sang Kim & Joong Bae Ahn. (2023) Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon Cancer. Clinical Colorectal Cancer 22:3, pages 307-317.
Crossref
Crossref
Lemei Zhu, Ran Xu, Leilei Yang, Wei Shi, Yuan Zhang, Juan Liu, Xi Li, Jun Zhou & Pingping Bing. (2023) Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review. Frontiers in Genetics 14.
Crossref
Crossref
Long Huynh Thanh, Khiem Nguyen Manh, Minh Nguyen Thi, Anh Nguyen Tri Trung, Kien Nguyen Trung, Thang Le Viet & Nung Vu Huy. (2023) Results of Laparoscopic Surgery and D3 Lymph Node Dissection Combined With Chemotherapy for the Radical Treatment of Advanced-Stage Right Colon Cancer: A Single-Center Observational Study in Vietnam. Cureus.
Crossref
Crossref
Michael J. Glover, Jeffrey Bien & Christopher T. Chen. (2023) Toward Precision Perioperative Therapy in GI Malignancies. JCO Precision Oncology:7.
Crossref
Crossref
Mengjie Luo, Chufan Tan, Ruiyun Cao, Chang Xiao, Jiahui Tian, Qi Li, Rushi Liu & Bin Liu. (2023) Hybrid membrane camouflaged Prussian blue nanoparticles with cinobufagin loading for chemo/photothermal therapy of colorectal cancer. Materials & Design 232, pages 112088.
Crossref
Crossref
Sergey A. Mertsalov, Evgeniy P. Kulikov, Vladimir V. Strel'nikov, Aleksey I. Kalinkin, Evgeniya I. Shumskaya & Roman O. Piskunov. (2023) Comparative Analysis of Gene Expression Profile in Tumor and Healthy Tissue in Patients with Colorectal Cancer. I.P. Pavlov Russian Medical Biological Herald 31:2, pages 273-282.
Crossref
Crossref
Zhi-Zhong Xiong, Ming-Hao Xie, Xian-Zhe Li, Long-Yang Jin, Feng-Xiang Zhang, Shi Yin, Hua-Xian Chen & Lei Lian. (2023) Risk factors for postoperative recurrence in patients with stage II colorectal cancer. BMC Cancer 23:1.
Crossref
Crossref
Stacey A. Cohen, Minetta C. Liu & Alexey Aleshin. (2023) Practical recommendations for using ctDNA in clinical decision making. Nature 619:7969, pages 259-268.
Crossref
Crossref
Nataliya Pidkovka & Abbes Belkhiri. (2023) Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target. Frontiers in Oncology 13.
Crossref
Crossref
Ryan Cohen, Cameron F Platell, Melanie J McCoy, Katie Meehan & Kathy Fuller. (2023) Circulating tumour DNA in colorectal cancer management. British Journal of Surgery 110:7, pages 773-783.
Crossref
Crossref
Kevin J. Chang, David H. Kim, Tasneem K. Lalani, Viktoriya Paroder, Perry J. Pickhardt, Hiram Shaish & David D. B. Bates. (2023) Radiologic T staging of colon cancer: renewed interest for clinical practice. Abdominal Radiology 48:9, pages 2874-2887.
Crossref
Crossref
Jeffrey Roberson & Lillias Maguire. (2023) Epidemiological trends in stage IV colorectal cancer. Seminars in Colon and Rectal Surgery, pages 100967.
Crossref
Crossref
Theresa Schmalfuss & Hossein Taghizadeh. (2023) Lessons learned in adjuvant colorectal cancer. memo - Magazine of European Medical Oncology 16:2, pages 113-115.
Crossref
Crossref
Robert Yoon, Kate Wilkinson, Gabriel Gabriel, Nasreen Kadaan, Tara Roberts, Stephanie Lim, Ray Asghari, Cheok Soon Lee, Wei Chua & Weng Ng. (2023) Real‐world tolerance and outcomes of oxaliplatin‐based adjuvant chemotherapy for stage III colon cancer—Does dose intensity matter?. Asia-Pacific Journal of Clinical Oncology.
Crossref
Crossref
Sheng-Nan Ren, Zhan-Yi Zhang, Rui-Jie Guo, Da-Ren Wang, Fang-Fang Chen, Xue-Bo Chen & Xue-Dong Fang. (2023) Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer. World Journal of Gastroenterology 29:13, pages 1911-1941.
Crossref
Crossref
Susanna Slater, Annette Bryant, Hsiang-Chi Chen, Ruwaida Begum, Isma Rana, Maria Aresu, Clare Peckitt, Oleg Zhitkov, Retchel Lazaro-Alcausi, Victoria Borja, Rachel Powell, David Lowery, Michael Hubank, Thereasa Rich, Gayathri Anandappa, Ian Chau, Naureen Starling & David Cunningham. (2023) ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C). BMC Cancer 23:1.
Crossref
Crossref
Andrea M. Mesiti, Julianna Brouwer, Mehraneh D. Jafari, Yuqing Qiu, Lari Wenzel, Joseph Carmichael, Chelsea McKinney, Jason A. Zell & Alessio Pigazzi. (2023) Assessment of Attitudes Toward Initiation of Immediate Adjuvant Chemotherapy for Colon Cancer. Journal of Surgical Research 283, pages 658-665.
Crossref
Crossref
Jonadab E Olguin, Monica G Mendoza-Rodriguez, C Angel Sanchez-Barrera & Luis I Terrazas. (2023) Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?. World Journal of Gastrointestinal Oncology 15:2, pages 251-267.
Crossref
Crossref
Paulo Garcia, Douglas Hartman, Haroon Choudry & Reetesh K. Pai. (2023) CD8+ T-cell Density Is an Independent Predictor of Survival and Response to Adjuvant Chemotherapy in Stage III Colon Cancer. Applied Immunohistochemistry & Molecular Morphology 31:2, pages 69-76.
Crossref
Crossref
Ines Beilmann-Lehtonen, Jussi Kasurinen, Jaana Hagström, Tuomas Kaprio, Camilla Böckelman & Caj Haglund. (2023) High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients. PLOS ONE 18:1, pages e0280085.
Crossref
Crossref
Lulu Tan, Daan Fu, Feng Liu, Jia Liu, Yang Zhang, Xin Li, Jinbo Gao, Kaixiong Tao, Guobin Wang, Lin Wang & Zheng Wang. (2023) MXRA8 is an immune-relative prognostic biomarker associated with metastasis and CD8+ T cell infiltration in colorectal cancer. Frontiers in Oncology 12.
Crossref
Crossref
Syreen Hassan, Anne Miles, Bernard Rachet & Melanie Morris. (2023) Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in England. Journal of Gastrointestinal Cancer.
Crossref
Crossref
Mounatadher Al-duhaidahawi. (2023) Role of CDX2 Marker in Patients with Colorectal Cancer. Biomedicine and Chemical Sciences 2:1.
Crossref
Crossref
Sakti Chakrabarti & Amit Mahipal. (2023) Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer. Pharmacogenomics 24:1, pages 1-4.
Crossref
Crossref
Ambrose H. N. Wong, Brigette Ma & Rashid N. Lui. (2023) New developments in targeted therapy for metastatic colorectal cancer. Therapeutic Advances in Medical Oncology 15, pages 175883592211485.
Crossref
Crossref
Stephanie L. Alden, Harmeet Dhani, Charuta C. Palsuledesai, Shifra Krinshpun, Adham Jurdi, Eric Christenson, Ilene Browner & Samuel Rosner. (2022) Post-operative ctDNA monitoring in stage I colon cancer: A case report. Frontiers in Oncology 12.
Crossref
Crossref
Haibo Wang, Wenjing Yang, Qiong Qin, Xiaomei Yang, Ying Yang, Hua Liu, Wenxiu Lu, Siyu Gu, Xuedi Cao, Duiping Feng, Zhongtao Zhang & Junqi He. (2022) E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer. Molecular Cancer 21:1.
Crossref
Crossref
Tobias Olenius, Laura Koskenvuo, Selja Koskensalo, Anna Lepistö & Camilla Böckelman. (2022) Long-term survival among colorectal cancer patients in Finland, 1991–2015: a nationwide population-based registry study. BMC Cancer 22:1.
Crossref
Crossref
Shania M Corry, Amy MB McCorry, Tamsin RM Lannagan, Niamh A Leonard, Natalie C Fisher, Ryan M Byrne, Petros Tsantoulis, Xabier Cortes-Lavaud, Raheleh Amirkhah, Keara L Redmond, Aoife J McCooey, Sudhir B Malla, Emily Rogan, Svetlana Sakhnevych, Michael A Gillespie, Mark White, Susan D Richman, Rene-Filip Jackstadt, Andrew D Campbell, Sarah Maguire, Simon S McDade, Daniel B Longley, Maurice B Loughrey, Helen G Coleman, Emma M Kerr, Sabine Tejpar, Timothy Maughan, Simon J Leedham, Donna M Small, Aideen E Ryan, Owen J Sansom, Mark Lawler & Philip D Dunne. (2022) Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut 71:12, pages 2502-2517.
Crossref
Crossref
Phoenix D Bell & Reetesh K Pai. (2022) Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker. Histopathology 81:6, pages 696-714.
Crossref
Crossref
Junjie Mi, Xiaofang Han, Rong Wang, Ruijun Ma & Danyu Zhao. (2022)
Circulation tumour
DNA
in predicting recurrence and prognosis in operable colorectal cancer patients: A meta‐analysis
. European Journal of Clinical Investigation 52:12.
Crossref
Crossref
Ursula Bisang, Jonas Zeitz, Stefan Groth, Matthias von Allmen, Paul Magnus Schneider & Panagiotis Samaras. (2022) Diagnostik und Therapie des KolonkarzinomsDiagnostic et traitement du cancer du côlonDiagnostica e terapia del carcinoma del colon. Schweizer Gastroenterologie 3:4, pages 130-143.
Crossref
Crossref
Corrado Pedrazzani, Giulia Turri, Daniele Marrelli, Hye Jin Kim, Eun Jung Park, Gaya Spolverato, Caterina Foppa, Antonino Spinelli, Salvatore Pucciarelli, Seung Hyuk Baik & Gyu Seog Choi. (2022) Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort. Annals of Surgical Oncology 29:12, pages 7896-7906.
Crossref
Crossref
Osamah S Niaz, Max Seabrook, Talha Niaz, Irfan Ahmed, Rebecca Parrott & Ahsan Rao. (2022) Effects of different weight loss programmes on oncological outcomes following curative resection of digestive tract cancers. Cochrane Database of Systematic Reviews 2022:10.
Crossref
Crossref
Daniel Sur, Alecsandra Gorzo & Claudia Burz. 2022. Recent Understanding of Colorectal Cancer Treatment. Recent Understanding of Colorectal Cancer Treatment.
Sebastian Foersch, Corinna Lang-Schwarz, Markus Eckstein, Carol Geppert, Maxime Schmitt, Björn Konukiewitz, Tanja Groll, Felix Schicktanz, Jutta Engel, Moritz Gleitsmann, Christina C. Westhoff, Nadine Frickel, Anne-Sophie Litmeyer, Albert Grass, Paul Jank, Sebastian Lange, Markus Tschurtschenthaler, Dirk Wilhelm, Wilfried Roth, Michael Vieth, Carsten Denkert, Iris Nagtegaal, Wilko Weichert & Moritz Jesinghaus. (2022) pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas—proposal for a new pT3a/pT3b subclassification. British Journal of Cancer 127:7, pages 1270-1278.
Crossref
Crossref
Brendan L. Hagerty, John G. Aversa, Dana A. Dominguez, Jeremy L. Davis, Jonathan M. Hernandez, James T. McCormick & Andrew M. Blakely. (2022) Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer. Diseases of the Colon & Rectum 65:10, pages 1206-1214.
Crossref
Crossref
C. Galindo-Pumariño, M. Collado, M.E. Castillo, J. Barquín, E. Romio, M.J. Larriba, G.J. Muñoz de Mier, A. Carrato, C. de la Pinta & C. Pena. (2022) SNAI1-expressing fibroblasts and derived-extracellular matrix as mediators of drug resistance in colorectal cancer patients. Toxicology and Applied Pharmacology 450, pages 116171.
Crossref
Crossref
Thais Reif de Paula, Prakash Gorroochurn, Eric M. Haas & Deborah S. Keller. (2022) A national evaluation of the predictors of compliance and survival from adjuvant chemotherapy in high-risk stage II colon cancer: A National Cancer Database (NCDB) analysis. Surgery 172:3, pages 859-868.
Crossref
Crossref
Corrado Pedrazzani, Hye Jin Kim, Eun Jung Park, Giulia Turri, Gaia Zagolin, Caterina Foppa, Seung Hyuk Baik, Gaya Spolverato, Antonino Spinelli & Gyu Seog Choi. (2022) Does laparoscopy increase the risk of peritoneal recurrence after resection for pT4 colon cancer? Results of a propensity score-matched analysis from an international cohort. European Journal of Surgical Oncology 48:8, pages 1823-1830.
Crossref
Crossref
Olatunji B. Alese, Natalie Cook, Ana Ortega-Franco, Mark B. Ulanja, Lavinia Tan & Jeanne Tie. (2022) Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers. American Society of Clinical Oncology Educational Book:42, pages 279-298.
Crossref
Crossref
Yaqi Li, Shaobo Mo, Long Zhang, Xiaoji Ma, Xiang Hu, Dan Huang, Binbin Lu, Chonglin Luo, Haixiang Peng, Sanjun Cai, Weiqi Sheng & Junjie Peng. (2022) Postoperative circulating tumor DNA combined with consensus molecular subtypes can better predict outcomes in stage III colon cancers: A prospective cohort study. European Journal of Cancer 169, pages 198-209.
Crossref
Crossref
Sakti Chakrabarti, Anup Kumar Kasi, Aparna R. Parikh & Amit Mahipal. (2022) Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC). Cancers 14:13, pages 3078.
Crossref
Crossref
Lorenzo Macchi, Quoc Riccardo Bao, Laura Albertoni, Matteo Fassan, Valentina Chiminazzo, Marco Scarpa, Gaya Spolverato & Salvatore Pucciarelli. (2022) Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer. International Journal of Clinical Oncology.
Crossref
Crossref
Jeanne Tie, Joshua D. CohenKamel Lahouel, Serigne N. LoYuxuan WangSuzanne KosmiderRachel Wong, Jeremy ShapiroMargaret LeeSam HarrisAdnan KhattakMatthew BurgeMarion HarrisJames Lynam, Louise NottFiona DayTheresa HayesSue-Anne McLachlanBelinda LeeJanine PtakNatalie SillimanLisa DobbynMaria PopoliRalph HrubanAnne Marie LennonNicholas PapadopoulosKenneth W. KinzlerBert VogelsteinCristian TomasettiPeter Gibbs. (2022) Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer. New England Journal of Medicine 386:24, pages 2261-2272.
Crossref
Crossref
Richard J. StrakerIIIIII, Danny H.J. Heo, Adrienne B. Shannon, Douglas L. Fraker, Skandan Shanmugan, Charles J. Schneider, Najjia N. Mahmoud, John T. Miura & Giorgos C. Karakousis. (2022) Predictive risk-score model for selection of patients with high-risk stage II colon cancer for adjuvant systemic therapy. Surgery 171:6, pages 1473-1479.
Crossref
Crossref
Caixia Sun, Bingbing Li, Genxia Wei, Weihao Qiu, Danyi Li, Xiangzhao Li, Xiangyu Liu, Wei Wei, Shuo Wang, Zhenyu Liu, Jie Tian & Li Liang. (2022) Deep learning with whole slide images can improve the prognostic risk stratification with stage III colorectal cancer. Computer Methods and Programs in Biomedicine 221, pages 106914.
Crossref
Crossref
Geoffrey Yuet Mun Wong, Connie Diakos, Thomas J. Hugh & Mark P. Molloy. (2022) Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases. International Journal of Molecular Sciences 23:11, pages 6091.
Crossref
Crossref
Pashtoon M. Kasi, Gordon Fehringer, Hiroya Taniguchi, Naureen Starling, Yoshiaki Nakamura, Daisuke Kotani, Thomas Powles, Bob T. Li, Lajos Pusztai, Vasily N. Aushev, Ekaterina Kalashnikova, Shruti Sharma, Meenakshi Malhotra, Zachary P. Demko, Alexey Aleshin, Angel Rodriguez, Paul R. Billings, Axel Grothey, Julien Taieb, David Cunningham, Takayuki Yoshino & Scott Kopetz. (2022) Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors. JCO Precision Oncology:6.
Crossref
Crossref
Matthew G. Davey, Gerard Feeney, Heidi Annuk, Maxwell Paganga, Emma Holian, Aoife J. Lowery, Michael J. Kerin & Nicola Miller. (2022) MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer. Cancers 14:9, pages 2109.
Crossref
Crossref
Maria F. Arisi, Efrat Dotan & Sandra V. Fernandez. (2022) Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer. International Journal of Molecular Sciences 23:8, pages 4441.
Crossref
Crossref
Geriolda Topi, Souvik Ghatak, Shakti Ranjan Satapathy, Roy Ehrnström, Marie-Louise Lydrup & Anita Sjölander. (2022) Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients. Frontiers in Medicine 9.
Crossref
Crossref
Allan M. Golder, Donald C. McMillan, Paul G. Horgan & Campbell S. D. Roxburgh. (2022) Determinants of emergency presentation in patients with colorectal cancer: a systematic review and meta-analysis. Scientific Reports 12:1.
Crossref
Crossref
Nancy N. Baxter, Erin B. Kennedy, Emily Bergsland, Jordan Berlin, Thomas J. George, Sharlene Gill, Philip J. Gold, Alex Hantel, Lee Jones, Christopher Lieu, Najjia Mahmoud, Arden M. Morris, Erika Ruiz-Garcia, Y. Nancy You & Jeffrey A. Meyerhardt. (2022) Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. Journal of Clinical Oncology 40:8, pages 892-910.
Crossref
Crossref
En Cheng, Fang-Shu Ou, Chao Ma, Donna Spiegelman, Sui Zhang, Xin Zhou, Tiffany M. Bainter, Leonard B. Saltz, Donna Niedzwiecki, Robert J. Mayer, Renaud Whittom, Alexander Hantel, Al Benson, Daniel Atienza, Michael Messino, Hedy Kindler, Edward L. Giovannucci, Erin L. Van Blarigan, Justin C. Brown, Kimmie Ng, Cary P. Gross, Jeffrey A. Meyerhardt & Charles S. Fuchs. (2022) Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance). Journal of Clinical Oncology 40:7, pages 740-751.
Crossref
Crossref
Michaela Ramser, Rene Warschkow, Carsten T. Viehl, Christoph Kettelhack, Andreas Zettl, Leonard A. Lobbes, Markus Zuber & Benjamin Weixler. (2021) The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer—Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination. World Journal of Surgery 46:3, pages 680-689.
Crossref
Crossref
Kabytto Chen, Henry Wang, Geoffrey Collins, Emma Hollands, Irene Yuen Jing Law & James Wei Tatt Toh. (2022) Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer. Current Oncology 29:3, pages 1370-1389.
Crossref
Crossref
Sijie Zha, Ting Li, Qingshan Zheng & Lujin Li. (2022) Whether Patients With Stage Ⅱ/Ⅲ Colorectal Cancer Benefit From Adjuvant Chemotherapy: A Modeling Analysis of Literature Aggregate Data. Frontiers in Pharmacology 13.
Crossref
Crossref
Sebastian Stasik, Marika Mende, Caroline Schuster, Sandra Mahler, Daniela Aust, Andrea Tannapfel, Anke Reinacher-Schick, Gustavo Baretton, Claudia Krippendorf, Martin Bornhäuser, Gerhard Ehninger, Gunnar Folprecht & Christian Thiede. (2022) Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer. Frontiers in Genetics 12.
Crossref
Crossref
Thais Reif de Paula, Prakash Gorroochurn, Hillary L. Simon, Eric M. Haas & Deborah S. Keller. (2021) A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database. Colorectal Disease 24:1, pages 40-49.
Crossref
Crossref
Hanke Zheng, Jeffrey S. McCombs & Afsaneh Barzi. (2022) Provider imaging practices and outcomes of advanced colorectal cancer. Cancer Treatment and Research Communications 32, pages 100624.
Crossref
Crossref
Ester Oneda & Alberto Zaniboni. (2022) Adjuvant treatment of colon cancer with microsatellite instability – the state of the art. Critical Reviews in Oncology/Hematology 169, pages 103537.
Crossref
Crossref
Dedecker Hans, Vandamme Timon, Teuwen Laure-Anne, Wuyts Laura, Prenen Hans, ten Tije, Albert Jan & Peeters Marc. 2022. The Lymphatic System in Colorectal Cancer. The Lymphatic System in Colorectal Cancer
257
271
.
Yi-Hsuan Huang, Peng-Chan Lin, Wu-Chou Su, Ren-Hao Chan, Po-Chuan Chen, Bo-Wen Lin, Meng-Ru Shen, Shang-Hung Chen & Yu-Min Yeh. (2021) Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer. Diagnostics 11:12, pages 2308.
Crossref
Crossref
Caroline Huynh, Stephanie Minkova, Diane Kim, Heather Stuart & Trevor D. Hamilton. (2021) Laparoscopic versus open resection in patients with locally advanced colon cancer. Surgery 170:6, pages 1610-1615.
Crossref
Crossref
Guillermo Valenzuela, Joaquín Canepa, Carolina Simonetti, Loreto Solo de Zaldívar, Katherine Marcelain & Jaime González-Montero. (2021) Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach. World Journal of Clinical Oncology 12:11, pages 1000-1008.
Crossref
Crossref
Carolina de la Pinta, María E. Castillo, Manuel Collado, Cristina Galindo-Pumariño & Cristina Peña. (2021) Radiogenomics: Hunting Down Liver Metastasis in Colorectal Cancer Patients. Cancers 13:21, pages 5547.
Crossref
Crossref
Long‐Wei Lin, Peng‐Sheng Lai, Ying‐Yin Chen & Chung‐Yu Chen. (2021) Expression of astrocyte‐elevated gene‐1 indicates prognostic value of fluoropyrimidine‐based adjuvant chemotherapy in resectable stage III colorectal cancer. Pathology International 71:11, pages 752-764.
Crossref
Crossref
Lina M. Olsson, Gudrun E. Lindmark, Anne C.E. Israelsson, Dejan Korkocic, Sten G. Hammarström & Marie-Louise K.C. Hammarström. (2021) CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer. Diseases of the Colon & Rectum 64:11, pages 1354-1363.
Crossref
Crossref
Benedikt Martin, Juliana P. L. Gonçalves, Christine Bollwein, Florian Sommer, Gerhard Schenkirsch, Anne Jacob, Armin Seibert, Wilko Weichert, Bruno Märkl & Kristina Schwamborn. (2021) A Mass Spectrometry Imaging Based Approach for Prognosis Prediction in UICC Stage I/II Colon Cancer. Cancers 13:21, pages 5371.
Crossref
Crossref
Liyun Ji, Jihong Fu, Jie Hao, Yin Ji, Huiyu Wang, Zeyuan Wang, Peng Wang & Hua Xiao. (2021) Proteomics analysis of tissue small extracellular vesicles reveals protein panels for the reoccurrence prediction of colorectal cancer. Journal of Proteomics 249, pages 104347.
Crossref
Crossref
Kai-Yen Peng, Shih-Sheng Jiang, Yu-Wei Lee, Fang-Yu Tsai, Chia-Chi Chang, Li-Tzong Chen & B. Linju Yen. (2021) Stromal Galectin-1 Promotes Colorectal Cancer Cancer-Initiating Cell Features and Disease Dissemination Through SOX9 and β-Catenin: Development of Niche-Based Biomarkers. Frontiers in Oncology 11.
Crossref
Crossref
Pashtoon Murtaza Kasi, Sarah Sawyer, Jessica Guilford, Michelle Munro, Sascha Ellers, Jacob Wulff, Nicole Hook, Shifra Krinshpun, Allyson Koyen Malashevich, Meenakshi Malhotra, Angel Rodriguez, Solomon Moshkevich, Axel Grothey, Scott Kopetz, Paul Billings & Alexey Aleshin. (2021) BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer. BMJ Open 11:9, pages e047831.
Crossref
Crossref
Reetesh K Pai, Douglas Hartman, David F Schaeffer, Christophe Rosty, Sameer Shivji, Richard Kirsch & Rish K Pai. (2021) Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters. Histopathology 79:3, pages 391-405.
Crossref
Crossref
Dan Jiang, Tarjei S. Hveem, Mark Glaire, David N. Church, David J. Kerr, Li Yang & Håvard E. Danielsen. (2021) Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer. eBioMedicine 71, pages 103547.
Crossref
Crossref
Haytham Ali, Lina Olsson, Gudrun Lindmark, Marie-Louise Hammarström, Sten Hammarström & Basel Sitohy. (2021) The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer. Tumor Biology 43:1, pages 209-223.
Crossref
Crossref
Chul Seung Lee, Hoon Seok Kim, Jeoffrey Schageman, In Kyu Lee, Myungshin Kim & Yonggoo Kim. (2021) Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing. Cancers 13:16, pages 4190.
Crossref
Crossref
Emily A. Verbus, Alexander J. Rossi, Allen J. Luna, Atif Iqbal, Van K. Morris & Jonathan M. Hernandez. (2021) Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA). Annals of Surgical Oncology 28:8, pages 4095-4097.
Crossref
Crossref
Yat Hang To, Koen Degeling, Suzanne Kosmider, Rachel Wong, Margaret Lee, Catherine Dunn, Grace Gard, Azim Jalali, Vanessa Wong, Maarten IJzerman, Peter Gibbs & Jeanne Tie. (2021) Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer. PharmacoEconomics 39:8, pages 953-964.
Crossref
Crossref
Umama Khan, Sabrina Chowdhury, Md Morsaline Billah, Kazi Mohammed Didarul Islam, Henrik Thorlacius & Milladur Rahman. (2021) Neutrophil Extracellular Traps in Colorectal Cancer Progression and Metastasis. International Journal of Molecular Sciences 22:14, pages 7260.
Crossref
Crossref
P Hansdotter, P Scherman, S H Petersen, M Mikalonis, E Holmberg, M Rizell, P Naredi & I Syk. (2021) Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial. BJS Open 5:4.
Crossref
Crossref
Anwar Algaber, Raed Madhi, Avin Hawez, Carl-Fredrik Rönnow & Milladur Rahman. (2021) Targeting FHL2‑E‑cadherin axis by miR‑340‑5p attenuates colon cancer cell migration and invasion. Oncology Letters 22:2.
Crossref
Crossref
Paula Pellenz Tomasini, Temenouga Nikolova Guecheva, Natalia Motta Leguisamo, Sarah Péricart, Anne-Cécile Brunac, Jean Sébastien Hoffmann & Jenifer Saffi. (2021) Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer. Cancers 13:13, pages 3130.
Crossref
Crossref
Laura Masfarré, Joana Vidal, Concepción Fernández-Rodríguez & Clara Montagut. (2021) ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC). Cancers 13:12, pages 2869.
Crossref
Crossref
Hallgeir Selven, Lill-Tove Rasmussen Busund, Sigve Andersen, Roy M. Bremnes & Thomas Karsten Kilvær. (2021) High expression of microRNA-126 relates to favorable prognosis for colon cancer patients. Scientific Reports 11:1.
Crossref
Crossref
Stefan Schiele, Tim Tobias Arndt, Benedikt Martin, Silvia Miller, Svenja Bauer, Bettina Monika Banner, Eva-Maria Brendel, Gerhard Schenkirsch, Matthias Anthuber, Ralf Huss, Bruno Märkl & Gernot Müller. (2021) Deep Learning Prediction of Metastasis in Locally Advanced Colon Cancer Using Binary Histologic Tumor Images. Cancers 13:9, pages 2074.
Crossref
Crossref
Ilmo Kellokumpu, Matti Kairaluoma, Jukka-Pekka Mecklin, Henrik Kellokumpu, Ville Väyrynen, Erkki-Ville Wirta, Eero Sihvo, Teijo Kuopio & Toni T. Seppälä. (2021) Impact of Age and Comorbidity on Multimodal Management and Survival from Colorectal Cancer: A Population-Based Study. Journal of Clinical Medicine 10:8, pages 1751.
Crossref
Crossref
Michaela Ramser, Leonard A. Lobbes, Rene Warschkow, Carsten T. Viehl, Johannes C. Lauscher, Raoul A. Droeser, Christoph Kettelhack, Markus Zuber & Benjamin Weixler. (2021) Evaluation of the prognostic relevance of the recommended minimum number of lymph nodes in colorectal cancer—a propensity score analysis. International Journal of Colorectal Disease 36:4, pages 779-789.
Crossref
Crossref
Ru Jia, Ningning Liu, Guoxiang Cai, Yun Zhang, Haijuan Xiao, Lihong Zhou, Qing Ji, Ling Zhao, Puhua Zeng, Huaimin Liu, Jiege Huo, Xiaoqiang Yue, Yi Zhang, Chaojun Wu, Xiaoting Sun, Yuanyuan Feng, Hongjie Liu, Hui Liu, Zhifen Han, Youying Lai, Yanbo Zhang, Gang Han, Hangjun Gong, Yan Wang & Qi Li. (2021) Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Frontiers in Oncology 11.
Crossref
Crossref
Jared A. Sninsky, Kumar S. Bishnupuri, Iván González, Nikolaos A. Trikalinos, Ling Chen & Brian K. Dieckgraefe. (2021) Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer. Oncotarget 12:4, pages 278-291.
Crossref
Crossref
Viet H. Le, Lucas Thornblade, Phillip H. G. Ituarte, Lily L. Lai & Kurt A. Melstrom. (2020) Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence. Journal of Surgical Oncology 123:2, pages 622-629.
Crossref
Crossref
James W. T. Toh, Hema Mahajan, Pierre Chapuis & Kevin Spring. (2020) Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists. Cancer Reports 4:1.
Crossref
Crossref
DeepS Pruthi, ManishB Pandey & Puneet Nagpal. (2021) Adjuvant chemotherapy for stage II colon cancer: Whom to treat?. Journal of Current Oncology 4:2, pages 102.
Crossref
Crossref
Ines Beilmann-Lehtonen, Jaana Hagström, Tuomas Kaprio, Ulf-Håkan Stenman, Karin Strigård, Richard Palmqvist, Ulf Gunnarsson, Camilla Böckelman & Caj Haglund. (2021) The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients. Oncology 99:12, pages 790-801.
Crossref
Crossref
Ines Beilmann-Lehtonen, Jaana Hagström, Harri Mustonen, Selja Koskensalo, Caj Haglund & Camilla Böckelman. (2021) High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients. Oncology 99:9, pages 589-600.
Crossref
Crossref
Benjamin Weixler, Michaela Ramser, Rene Warschkow, Carsten T. Viehl, Peter G. Vaughan-Shaw, Andreas Zettl, Christoph Kettelhack & Markus Zuber. (2021) The Value of Sentinel Lymph Node Mapping for the Staging of Node-Negative Colon Cancer. Annals of Surgery Open 2:3, pages e084.
Crossref
Crossref
Daniel W. Nelson, Clay Merritt, Shu-Ching Chang, Gary Grunkemeier, Scott R. Steele & Melanie Goldfarb. (2020) Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer. Journal of Gastrointestinal Surgery 25:1, pages 220-232.
Crossref
Crossref
Pietro Achilli, Jacopo Crippa, Fabian Grass, Kellie L. Mathis, Anne‐Lise D. D'Angelo, Mohamed A. Abd El Aziz, Courtney N. Day, William S. Harmsen & David W. Larson. (2020)
Survival impact of adjuvant chemotherapy in patients with stage
IIA
colon cancer: Analysis of the National Cancer Database
. International Journal of Cancer 148:1, pages 161-169.
Crossref
Crossref
Roberto Dinami, Manuela Porru, Carla Azzurra Amoreo, Isabella Sperduti, Marcella Mottolese, Simonetta Buglioni, Daniele Marinelli, Marcello Maugeri-Saccà, Andrea Sacconi, Giovanni Blandino, Carlo Leonetti, Giuliana Di Rocco, Alessandra Verdina, Francesca Spinella, Francesco Fiorentino, Gennaro Ciliberto, Annamaria Biroccio & Pasquale Zizza. (2020) TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh & Saeed Samarghandian. (2020) Flaming the fight against cancer cells: the role of microRNA-93. Cancer Cell International 20:1.
Crossref
Crossref
S. J. Schraa, K. L. van Rooijen, D. E. W. van der Kruijssen, C. Rubio Alarcón, J. Phallen, M. Sausen, J. Simmons, V. M. H. Coupé, W. M. U. van Grevenstein, S. Elias, H. M. Verkooijen, M. M. Laclé, L. J. W. Bosch, D. van den Broek, G. A. Meijer, V. E. Velculescu, R. J. A. Fijneman, G. R. Vink & M. Koopman. (2020) Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study. BMC Cancer 20:1.
Crossref
Crossref
Amirhossein Jahangiri, Maryam Dadmanesh & Khodayar Ghorban. (2020) STAT3 inhibition reduced PD‐L1 expression and enhanced antitumor immune responses. Journal of Cellular Physiology 235:12, pages 9457-9463.
Crossref
Crossref
Erik Osterman, Klara Hammarström, Israa Imam, Emerik Osterlund, Tobias Sjöblom & Bengt Glimelius. (2020) Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?. Cancers 12:11, pages 3308.
Crossref
Crossref
Samvel Bardakhchyan, Sergo Mkhitaryan, Davit Zohrabyan, Liana Safaryan, Armen Avagyan, Lilit Harutyunyan, Jemma Arakelyan, Gevorg Tamamyan & Armen Tananyan. (2020) Treatment and Outcomes of Colorectal Cancer in Armenia: A Real-World Experience From a Developing Country. JCO Global Oncology:6, pages 1286-1297.
Crossref
Crossref
A. N. Akimniyazova, A. Yu. Pyrkova, D. E. Aisina & A. T. Ivashchenko. (2021) miRNA Binding Site Clusters in mRNAs of Colorectal Cancer Candidate Genes. Nanotechnologies in Russia 15:11-12, pages 807-818.
Crossref
Crossref
Ines Beilmann-Lehtonen, Camilla Böckelman, Harri Mustonen, Selja Koskensalo, Jaana Hagström & Caj Haglund. (2020) The prognostic role of tissue TLR2 and TLR4 in colorectal cancer. Virchows Archiv 477:5, pages 705-715.
Crossref
Crossref
C. Simillis, H. K. S. I. Singh, T. Afxentiou, S. Mills, O. J. Warren, J. J. Smith, P. Riddle, M. Adamina, D. Cunningham & P. P. Tekkis. (2020) Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis. Colorectal Disease 22:10, pages 1231-1244.
Crossref
Crossref
Peng-ju Chen, Tian-le Li, Ting-ting Sun, Van C. Willis, M. Christopher Roebuck, Dena M. Bravata, Xin-zhi Liu, Yull E. Arriaga, Irene Dankwa-Mullan & Ai-wen Wu. (2020) Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival. Diseases of the Colon & Rectum 63:10, pages 1383-1392.
Crossref
Crossref
Soo Young Lee, Seung-Seop Yeom, Chang Hyun Kim & Hyeong Rok Kim. (2020) Nutritional risk screening score is associated with omission of adjuvant chemotherapy for stage III colon cancer. The American Journal of Surgery 220:4, pages 993-998.
Crossref
Crossref
A. Carrara, M. Motter, D. Amabile, L. Pellecchia, P. Moscatelli, R. Pertile, M. Barbareschi, N. L. Decarli, M. Ferrari & G. Tirone. (2020) Predictive value of the sentinel lymph node procedure in the staging of non-metastatic colorectal cancer. International Journal of Colorectal Disease 35:10, pages 1921-1928.
Crossref
Crossref
Brett S. Walker, Luai R. Zarour, Nicole Wieghard, Alexandra C. Gallagher, John R. Swain, Sheila Weinmann, Christian Lanciault, Kevin Billingsley, V. Liana Tsikitis & Melissa H. Wong. (2020) Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia. World Journal of Surgery 44:10, pages 3501-3509.
Crossref
Crossref
Sakti Chakrabarti, Hao Xie, Raul Urrutia & Amit Mahipal. (2020) The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review. Cancers 12:10, pages 2808.
Crossref
Crossref
Catalin Alius, Corneliu Tudor, Cristinel Dumitru Badiu, Ana Maria Dascalu, Catalin Gabriel Smarandache, Alexandru Dan Sabau, Ciprian Tanasescu, Simona Andreea Balasescu & Dragos Serban. (2020) Indocyanine Green-Enhanced Colorectal Surgery—between Being Superfluous and Being a Game-Changer. Diagnostics 10:10, pages 742.
Crossref
Crossref
Sara Elena Rebuzzi, Guido Pesola, Valentino Martelli & Alberto Felice Sobrero. (2020) Adjuvant Chemotherapy for Stage II Colon Cancer. Cancers 12:9, pages 2584.
Crossref
Crossref
Hailong Zheng, Kai Song, Yelin Fu, Tianyi You, Jing Yang, Wenbing Guo, Kai Wang, Liangliang Jin, Yunyan Gu, Lishuang Qi, Wenyuan Zhao & Zheng Guo. (2019) A qualitative transcriptional signature for determining the
grade of colorectal adenocarcinoma. Cancer Gene Therapy 27:9, pages 680-690.
Crossref
Crossref
Andreas Teufel, Michael Gerken, Alois Fürst, Matthias Ebert, Ina Hohenthanner & Monika Klinkhammer-Schalke. (2020) Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer. European Journal of Cancer 137, pages 148-160.
Crossref
Crossref
Sakti Chakrabarti, Carrie Y Peterson, Deepika Sriram & Amit Mahipal. (2020) Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions. World Journal of Gastrointestinal Oncology 12:8, pages 808-832.
Crossref
Crossref
Bengt Glimelius & Erik Osterman. (2020) Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients. Cancers 12:8, pages 2289.
Crossref
Crossref
Reetu Mukherji, John Marshall & Andreas Seeber. (2020) Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers 12:8, pages 2001.
Crossref
Crossref
Douglas J. Hartman, Madison Frank, Lindsey Seigh, Haroon Choudry, James Pingpank, Matthew Holtzman, David Bartlett, Nathan Bahary, Liron Pantanowitz & Reetesh K. Pai. (2020) Automated Quantitation of CD8-positive T Cells Predicts Prognosis in Colonic Adenocarcinoma With Mucinous, Signet Ring Cell, or Medullary Differentiation Independent of Mismatch Repair Protein Status. American Journal of Surgical Pathology 44:7, pages 991-1001.
Crossref
Crossref
Jinyuan Li, Linhai Li, Yuejin Li, Yaxin Long, Quan Zhao, Yiming Ouyang, Weimin Bao & Kunmei Gong. (2020) Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis. International Journal of Colorectal Disease 35:7, pages 1203-1210.
Crossref
Crossref
Geriolda Topi, Shakti Ranjan Satapathy, Pujarini Dash, Syrina Fred Mehrabi, Roy Ehrnström, Roger Olsson, Marie‐Louise Lydrup & Anita Sjölander. (2020) Tumour‐suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model. The Journal of Pathology 251:3, pages 297-309.
Crossref
Crossref
Chase Cockrell, Joseph Teague & David E. Axelrod. (2020) Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy. JCO Clinical Cancer Informatics:4, pages 514-520.
Crossref
Crossref
Ting Li, Zhiqiang Li, Hongxing Wan, Xifeng Tang, Han Wang, Fang Chai, Meng Zhang & Baochun Wang. (2020) Recurrence-Associated Long Non-coding RNA LNAPPCC Facilitates Colon Cancer Progression via Forming a Positive Feedback Loop with PCDH7. Molecular Therapy - Nucleic Acids 20, pages 545-557.
Crossref
Crossref
Shah Zeb Khan & Ismat Fatima. (2020) Early postoperative recurrences for colon cancer: Results from a Pakistani rural cohort. Journal of Taibah University Medical Sciences 15:3, pages 232-237.
Crossref
Crossref
Tatiana M. Villatoro, Changqing Ma & Reetesh K. Pai. (2020) Switch/sucrose nonfermenting nucleosome complex–deficient colorectal carcinomas have distinct clinicopathologic features. Human Pathology 99, pages 53-61.
Crossref
Crossref
M. J. Fernández-Aceñero, M. Cruz, J. Sastre-Varela, J. I. Casal, M. A. Cerón Nieto, L. del Puerto-Nevado, J. García-Foncillas & A. Cebrián. (2019) TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma. Pathology & Oncology Research 26:2, pages 861-865.
Crossref
Crossref
Weiting Ge, Hanguang Hu, Wen Cai, Jinhong Xu, Wangxiong Hu, Xingyue Weng, Xin Qin, Yanqin Huang, Weidong Han, Yeting Hu, Jiekai Yu, Wufeng Zhang, Sisi Ye, Lina Qi, Pingjie Huang, Lirong Chen, Kefeng Ding, Li Dong Wang & Shu Zheng. (2019) High‐risk Stage III colon cancer patients identified by a novel five‐gene mutational signature are characterized by upregulation of IL‐23A and gut bacterial translocation of the tumor microenvironment. International Journal of Cancer 146:7, pages 2027-2035.
Crossref
Crossref
David S. Williams, Dmitri Mouradov, Clare Browne, Michelle Palmieri, Meg J. Elliott, Rebecca Nightingale, Catherine G. Fang, Rita Li, John M. Mariadason, Ian Faragher, Ian T. Jones, Leonid Churilov, Niall C. Tebbutt, Peter Gibbs & Oliver M. Sieber. (2020) Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. Modern Pathology 33:3, pages 483-495.
Crossref
Crossref
Lina Olsson, Marie-Louise Hammarström, Anne Israelsson, Gudrun Lindmark & Sten Hammarström. (2020) Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis. PLOS ONE 15:2, pages e0229007.
Crossref
Crossref
Shanthi Sabarimurugan, Madurantakam Royam Madhav, Chellan Kumarasamy, Ajay Gupta, Siddharta Baxi, Sunil Krishnan & Rama Jayaraj. (2020) Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Molecular Diagnosis & Therapy 24:1, pages 15-30.
Crossref
Crossref
Jan Dimberg, Roland E. Andersson & Sofie Haglund. (2020) Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade. Oncology 98:8, pages 575-582.
Crossref
Crossref
Zhujun Deng, Yun Qin, Jing Wang, Gang Wang, Xiaoqiang Lang, Juan Jiang, Kang Xie, Wengeng Zhang, Heng Xu, Yang Shu & Yan Zhang. (2019) Prognostic and predictive role of DNA mismatch repair status in stage II‐III colorectal cancer: A systematic review and meta‐analysis. Clinical Genetics 97:1, pages 25-38.
Crossref
Crossref
MEHMET ZENGIN. (2019) Tümör stroma oranı, ameliyat sonrası nüks için kolorektal kanser hastalarının yüksek riskini tahmin edebilir. Ortadoğu Tıp Dergisi.
Crossref
Crossref
Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Harri Mustonen, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen & Caj Haglund. (2019) Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome. FASEB BioAdvances 1:12, pages 723-730.
Crossref
Crossref
Chaojie Liang, Tuanjie Zhao, Haijun Li, Fucheng He, Xin Zhao, Yuan Zhang, Xi Chu, Chunlan Hua, Yunhui Qu, Yu Duan, Liang Ming & Jiansheng Guo. (2019) Long Non-coding RNA ITIH4-AS1 Accelerates the Proliferation and Metastasis of Colorectal Cancer by Activating JAK/STAT3 Signaling. Molecular Therapy - Nucleic Acids 18, pages 183-193.
Crossref
Crossref
Megan Greally, Keith Pilson, Anna Linehan, Conor O’Keane, Conor J. Shields, John B. Conneely & John A. McCaffrey. (2018) Indolent Nodal Relapse of Colon Carcinoma with Associated Tumor Thrombus Invading the Superior Mesenteric Vein. Journal of Gastrointestinal Cancer 50:3, pages 660-664.
Crossref
Crossref
Kilian G M Brown, Michael J Solomon, Kate Mahon & Sarah O’Shannassy. (2019) Management of colorectal cancer. BMJ, pages l4561.
Crossref
Crossref
Artur Mezheyeuski, Ina Hrynchyk, Mercedes Herrera, Mia Karlberg, Eric Osterman, Peter Ragnhammar, David Edler, Anna Portyanko, Fredrik Ponten, Tobias Sjöblom, Bengt Glimelius & Arne Östman. (2019) Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer. British Journal of Cancer 121:4, pages 303-311.
Crossref
Crossref
Changqing Ma, Dane Olevian, Caitlyn Miller, Cameron Herbst, Priya Jayachandran, Margaret M. Kozak, Daniel T. Chang & Reetesh K. Pai. (2019) SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer. Modern Pathology 32:8, pages 1217-1231.
Crossref
Crossref
Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen, Shruti Sharma, Raheleh Salari, Himanshu Sethi, Michael Knudsen, Iver Nordentoft, Hsin-Ta Wu, Antony S. Tin, Mads Heilskov Rasmussen, Søren Vang, Svetlana Shchegrova, Amanda Frydendahl Boll Johansen, Ramya Srinivasan, Zoe Assaf, Mustafa Balcioglu, Alexander Olson, Scott Dashner, Dina Hafez, Samantha Navarro, Shruti Goel, Matthew Rabinowitz, Paul Billings, Styrmir Sigurjonsson, Lars Dyrskjøt, Ryan Swenerton, Alexey Aleshin, Søren Laurberg, Anders Husted Madsen, Anne-Sofie Kannerup, Katrine Stribolt, Søren Palmelund Krag, Lene H. Iversen, Kåre Gotschalck Sunesen, Cheng-Ho Jimmy Lin, Bernhard G. Zimmermann & Claus Lindbjerg Andersen. (2019) Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer. JAMA Oncology 5:8, pages 1124.
Crossref
Crossref
Hung-Chih Hsu, Jeng-Fu You, Shu-Jen Chen, Hua-Chien Chen, Chien-Yuh Yeh, Wen-Sy Tsai, Hsin-Yuan Hung, Tsai-Sheng Yang, Nina Lapke & Kien Thiam Tan. (2019) TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer. Cancers 11:8, pages 1079.
Crossref
Crossref
Luisa Seguella, Riccardo Capuano, Mirella Pesce, Giuseppe Annunziata, Marcella Pesce, Barbara de Conno, Giovanni Sarnelli, Laura Aurino & Giuseppe Esposito. (2019) S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells. International Journal of Molecular Sciences 20:13, pages 3240.
Crossref
Crossref
Sten Hammarström. (2019) Biomarker mRNAs as prognostic tools for lymph node analysis in colorectal cancer. Biomarkers in Medicine 13:10, pages 801-803.
Crossref
Crossref
Roberta Fusco, Vincenza Granata, Daniela Rega, Carolina Russo, Ugo Pace, Biagio Pecori, Fabiana Tatangelo, Gerardo Botti, Francesco Izzo, Marco Cascella, Antonio Avallone, Paolo Delrio & Antonella Petrillo. (2018) Morphological and functional features prognostic factor of magnetic resonance imaging in locally advanced rectal cancer. Acta Radiologica 60:7, pages 815-825.
Crossref
Crossref
Qingyang Feng, Wenju Chang, Yihao Mao, Guodong He, Peng Zheng, Wentao Tang, Ye Wei, Li Ren, Dexiang Zhu, Meiling Ji, Yongjiu Tu, Xinyu Qin & Jianmin Xu. (2019) Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer. Clinical Cancer Research 25:13, pages 3896-3907.
Crossref
Crossref
Junhui Yu, Ming Liu, Hui Liu & Lei Zhou. (2019) GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway. Molecular and Cellular Biochemistry 457:1-2, pages 191-199.
Crossref
Crossref
Haytham Ali, Manar AbdelMageed, Lina Olsson, Anne Israelsson, Gudrun Lindmark, Marie-Louise Hammarström, Sten Hammarström & Basel Sitohy. (2019) Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer. Tumor Biology 41:6, pages 101042831985888.
Crossref
Crossref
Gabriella Buccafusca, Ilaria Proserpio, Antonino Carmelo Tralongo, Sebastiano Rametta Giuliano & Paolo Tralongo. (2019) Early colorectal cancer: diagnosis, treatment and survivorship care. Critical Reviews in Oncology/Hematology 136, pages 20-30.
Crossref
Crossref
Hua Wei, Zhichao Yang & Bo Lin. (2019) Overexpression of long non coding RNA CA3-AS1 suppresses proliferation, invasion and promotes apoptosis via miRNA-93/PTEN axis in colorectal cancer. Gene 687, pages 9-15.
Crossref
Crossref
Kwan Mo Yang, In Ja Park, Jong Lyul Lee, Yong Sik Yoon, Chan Wook Kim, Seok-Byung Lim, Na Young Kim, Shinae Hong, Chang Sik Yu & Jin Cheon Kim. (2019) Does the Different Locations of Colon Cancer Affect the Oncologic Outcome? A Propensity-Score Matched Analysis. Annals of Coloproctology 35:1, pages 15-23.
Crossref
Crossref
Yibin Wu, Guojiu Fang, Xin Wang, Huipeng Wang, Wenjie Chen, Liang Li, Tao Ye, Lifeng Gong, Chongwei Ke & Yuankun Cai. (2019) NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis. Cancer Biomarkers 24:1, pages 61-70.
Crossref
Crossref
Matthew Skancke, Suzanne M. Arnott, Richard L. Amdur, Robert S. Siegel, Vincent J. Obias & Bindu A. Umapathi. (2019) Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon. Diseases of the Colon & Rectum 62:2, pages 181-188.
Crossref
Crossref
Anant Ramaswamy, Rushabh Kothari, Ashwin Desouza, Tarachand Gupta, Sandeep Bairwa, Akhil Kapoor, Amit Kumar, Pradeep Ventrapati, Mukta Ramadwar, Sarika Mandavkar, Nita Chavan, Avanish Saklani & Vikas Ostwal. (2019) Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX. South Asian Journal of Cancer 8:3, pages 160.
Crossref
Crossref
Toshiaki Ishikawa & Hiroyuki Uetake. 2019. Recent Advances in the Treatment of Colorectal Cancer. Recent Advances in the Treatment of Colorectal Cancer
81
100
.
Peter Bronsert & Martin Werner. 2019. Tumor Angiogenesis. Tumor Angiogenesis
253
274
.
Hyung Jin Kim. (2018) Adjuvant chemotherapy in patients with stage II colon cancer. Korean Journal of Clinical Oncology 14:2, pages 67-68.
Crossref
Crossref
Nikoletta Dimitriou, Evangelos Felekouras, Ioannis Karavokyros, Andreas Alexandrou, Emmanuel Pikoulis & John Griniatsos. (2018) Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. BMC Cancer 18:1.
Crossref
Crossref
Camilla Böckelman, Ines Beilmann-Lehtonen, Tuomas Kaprio, Selja Koskensalo, Taina Tervahartiala, Harri Mustonen, Ulf-Håkan Stenman, Timo Sorsa & Caj Haglund. (2018) Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. BMC Cancer 18:1.
Crossref
Crossref
Levar Shamoun, Marita Skarstedt, Roland E. Andersson, Dick Wågsäter & Jan Dimberg. (2018) Association study on IL-4, IL-4Rα and IL-13 genetic polymorphisms in Swedish patients with colorectal cancer. Clinica Chimica Acta 487, pages 101-106.
Crossref
Crossref
Hongyan Gong, Weicai Cheng & Yong Wang. (2018) Tumor necrosis factor‑related apoptosis‑inducing ligand inhibits the growth and aggressiveness of colon carcinoma via the exogenous apoptosis signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Xiaomei Huang, Zixuan Cheng, Yanqi Huang, Cuishan Liang, Lan He, Zelan Ma, Xin Chen, Xiaomei Wu, Yexing Li, Changhong Liang & Zaiyi Liu. (2018) CT-based Radiomics Signature to Discriminate High-grade From Low-grade Colorectal Adenocarcinoma. Academic Radiology 25:10, pages 1285-1297.
Crossref
Crossref
P. Sánchez-Velázquez, M. Pera, M. Jiménez-Toscano, X. Mayol, X. Rogés, L. Lorente, M. Iglesias & M. Gallén. (2018) Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer. Clinical and Translational Oncology 20:10, pages 1321-1328.
Crossref
Crossref
Displaying 200 of 237 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list